IRIS
MACKAY, ANDREW REAY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.269
EU - Europa 2.828
AS - Asia 2.778
SA - Sud America 363
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 48
OC - Oceania 7
Totale 11.486
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.184
SG - Singapore 1.119
CN - Cina 663
RU - Federazione Russa 622
IE - Irlanda 606
DE - Germania 323
IT - Italia 318
BR - Brasile 305
TR - Turchia 303
HK - Hong Kong 275
VN - Vietnam 233
GB - Regno Unito 183
SE - Svezia 181
UA - Ucraina 164
FI - Finlandia 132
FR - Francia 129
IN - India 56
CA - Canada 46
CZ - Repubblica Ceca 32
BD - Bangladesh 26
PL - Polonia 25
BE - Belgio 21
ES - Italia 21
MX - Messico 21
JP - Giappone 20
ZA - Sudafrica 20
AR - Argentina 18
AT - Austria 18
NL - Olanda 16
EC - Ecuador 11
IQ - Iraq 11
KR - Corea 11
LT - Lituania 9
EU - Europa 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
PK - Pakistan 7
UY - Uruguay 7
UZ - Uzbekistan 7
ID - Indonesia 6
EG - Egitto 5
VE - Venezuela 5
AU - Australia 4
DZ - Algeria 4
IL - Israele 4
KZ - Kazakistan 4
BH - Bahrain 3
BY - Bielorussia 3
CH - Svizzera 3
CO - Colombia 3
GR - Grecia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CR - Costa Rica 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GN - Guinea 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.296
Salva come PNG Salva come JPEG
Città #
Singapore 686
Jacksonville 647
Chandler 642
Dublin 605
San Jose 561
Dallas 409
Ashburn 325
Hong Kong 270
Santa Clara 236
Boardman 215
Council Bluffs 160
New York 146
Izmir 134
The Dalles 124
Nanjing 121
Beijing 115
Wilmington 115
San Mateo 99
Munich 86
Lawrence 85
Moscow 85
Princeton 85
Ho Chi Minh City 69
Lauterbourg 63
Los Angeles 62
Ann Arbor 54
Dearborn 53
Hanoi 52
Milan 51
Nanchang 48
L'aquila 46
Shenyang 37
Turku 33
São Paulo 32
Brno 30
Seattle 29
Hefei 27
Verona 26
Helsinki 25
Mountain View 25
Teramo 25
Tianjin 25
Frankfurt am Main 24
Orem 23
Rome 23
Des Moines 22
Dong Ket 22
Shanghai 22
Warsaw 22
Brussels 20
Falls Church 20
Columbus 19
Tokyo 19
Bremen 17
Hebei 17
Montreal 17
Denver 16
Brooklyn 15
Nuremberg 15
Philadelphia 15
Woodbridge 15
Chennai 14
L’Aquila 14
Boston 13
Impruneta 13
Guangzhou 12
Johannesburg 12
Stockholm 12
Toronto 12
Jinan 11
Kunming 11
Phoenix 11
Rio de Janeiro 11
Da Nang 10
Falkenstein 10
Jiaxing 10
London 10
Washington 10
Haiphong 9
Houston 9
Norwalk 9
Poplar 9
Vienna 9
Amsterdam 8
Atlanta 8
Chicago 8
Manchester 8
Ningbo 8
Pescara 8
Salvador 8
San Francisco 8
Taizhou 8
Zhengzhou 8
Ankara 7
Assisi 7
Brasília 7
Changsha 7
Curitiba 7
Hangzhou 7
Hải Dương 7
Totale 7.496
Salva come PNG Salva come JPEG
Nome #
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 185
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 175
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 175
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study 168
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 160
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 156
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 155
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 153
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 153
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 147
Multidisciplinary palliation for unresectable recurrent rectal cancer: Hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study 147
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 145
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 144
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 141
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 140
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 139
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 138
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen 138
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 138
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 137
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study 136
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 135
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 135
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 135
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 134
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 132
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 131
Successful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report 131
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 131
EGF- and cell-cycle-regulated STAG1/PMEPA1 ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer 130
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 130
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 128
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 127
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 124
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 122
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 120
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 120
The interaction of leucocytes with vascular endothelial cells in vitro with respect to experimental inflammation in the rat 120
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 120
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 120
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 117
Alternative TrkA splicing and neuroblastoma 115
TrkAIII expression in the thymus 115
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 114
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 114
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 114
Mode of formation of synovial villi 113
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 112
BASEMENT-MEMBRANE TYPE-IV COLLAGEN DEGRADATION - EVIDENCE FOR THE INVOLVEMENT OF A PROTEOLYTIC CASCADE INDEPENDENT OF METALLOPROTEINASES 111
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 110
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis 110
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 110
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 110
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 110
REN: a novel, developmentally regulated gene that promotes neural cell differentiation 110
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 109
The transition from acute to chronic inflammation 109
Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study 109
The effect of GRGDSP peptide, osteopontin and bone sialoprotein on metalloproteinases, tissue inhibitors of metalloproteinases, and plasminogen activators secreted by human osteoclastoma cells. 108
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 108
Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosis 108
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 106
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 106
Thioredoxin inhibits microvascular endothelial capillary tubule formation 106
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 106
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 104
Alternative TrkA splicing and Cancer 104
DIFFERENTIAL EXPRESSION OF TUMOR-CELL METALLOPROTEINASES AND TIMPS BY A PHORBOL ESTER 104
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 103
Identification of plasminogen in Matrigel(TM) and its activation by reconstitution of this basement membrane extract 102
MAPPING OF RECEPTOR-BINDING SITES ON IL-1-BETA BY RECONSTRUCTION OF IL-1RA-LIKE DOMAINS 102
Opposing roles for specific TIMPs in breast cancer prognostic 101
bcl-2 over-expression enhances NF-κB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells 101
IDENTIFICATION OF THE 72-KDA (MMP-2) AND 92-KDA (MMP-9) GELATINASE TYPE-IV COLLAGENASE IN PREPARATIONS OF LAMININ AND MATRIGEL(TM) 99
RAS LEVELS AND METALLOPROTEINASE ACTIVITY IN NORMAL VERSUS NEOPLASTIC RAT MAMMARY TISSUES 99
Effect of a lymphocyte-derived pro-inflammatory factor on carrageenan pleurisy in the rat 99
STUDIES ON THE EFFECTS OF LAMININ, E-8 FRAGMENT OF LAMININ AND SYNTHETIC LAMININ PEPTIDES PA22-2 AND YIGSR ON MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION 99
Alternative TrkAIII splicing and Cancer 98
EXPRESSION OF 72 KD GELATINASE AND TYPE-IV COLLAGEN DURING CARBON TETRACHLORIDE-INDUCED RAT-LIVER FIBROSIS 96
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 93
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 93
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 92
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 92
Studies into the mode of action of non-steroidal anti-inflammatory drugs using a model of facsimile synovium 92
The effects of levan on the acute inflammatory response 88
Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties 87
Pyrrolopyrimidine class Src inhibitors inhibit osteoclast and bone metastatic tumor cell functions. 85
Enhancement of colloidal clearance in normal rats by sodium diethyl dithiocarbamate (DTC) 85
STUDIES ON THE ABILITY OF 65-KDA AND 92-KDA TUMOR-CELL GELATINASES TO DEGRADE TYPE-IV COLLAGEN 85
The alternative TrkAIII splice variant expressed by human neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 83
Characterisation of metastatic tumour cells 81
The role of plasma factors in the adherence of leucocytes to vascular endothelial cells 80
Isolation and characterization of human natural killer cells 80
Effect of acute acupuncture on acute inflammation 78
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 77
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 71
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 51
Jurkat T-Cell Antigen-Independent Elimination of PMA-Activated Neuroblastoma Cells Is Triggered by CCL2/CCR2, Depends Upon Lipid Raft LFA1/ICAM1 Immune Synapses, Is Mediated by m-TRAIL and Is Augmented by the TrkAIII Oncoprotein 40
Alternative Splicing of the NF-Y Subunit, NF-YA, in Neuroblastoma Phenotype Heterogeneity 12
Totale 11.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 41 59 23 40 13 13 34 28 11 40 166
2022/20231.771 125 111 39 187 167 203 3 99 755 10 39 33
2023/2024464 59 23 43 46 31 135 1 22 5 13 8 78
2024/20252.005 50 33 163 98 236 167 291 169 344 139 167 148
2025/20263.913 173 348 311 524 408 258 603 110 358 560 189 71
2026/2027225 121 104 0 0 0 0 0 0 0 0 0 0
Totale 11.486